| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.94B | 3.87B | 3.79B | 3.92B | 3.72B | 3.09B |
| Gross Profit | 2.30B | 2.25B | 2.17B | 2.24B | 2.11B | 1.74B |
| EBITDA | 1.23B | 1.22B | 1.18B | 1.24B | 1.10B | 885.96M |
| Net Income | 835.73M | 863.14M | 788.78M | 872.50M | 768.99M | 602.74M |
Balance Sheet | ||||||
| Total Assets | 3.52B | 3.24B | 3.36B | 3.49B | 3.33B | 2.81B |
| Cash, Cash Equivalents and Short-Term Investments | 69.06M | 59.36M | 69.81M | 95.97M | 98.56M | 94.25M |
| Total Debt | 2.21B | 2.13B | 2.20B | 2.13B | 1.80B | 1.33B |
| Total Liabilities | 3.77B | 3.37B | 3.51B | 3.47B | 3.16B | 2.53B |
| Stockholders Equity | -249.20M | -126.89M | -149.94M | 24.79M | 171.42M | 282.68M |
Cash Flow | ||||||
| Free Cash Flow | 889.48M | 864.45M | 860.55M | 737.83M | 801.25M | 632.21M |
| Operating Cash Flow | 996.37M | 968.35M | 965.87M | 859.07M | 908.83M | 724.70M |
| Investing Cash Flow | -204.52M | -119.46M | -131.69M | -139.40M | -314.11M | -100.36M |
| Financing Cash Flow | -786.73M | -855.98M | -859.59M | -716.04M | -590.55M | -743.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $37.86B | 29.28 | 20.62% | 0.72% | 6.73% | 3.34% | |
73 Outperform | $22.08B | 34.09 | 32.99% | ― | 6.90% | 3.86% | |
71 Outperform | $28.05B | 34.25 | ― | ― | 4.77% | 7.93% | |
69 Neutral | $20.81B | 21.95 | 13.69% | 1.80% | 13.74% | 14.87% | |
67 Neutral | $154.61B | 43.34 | 7.05% | 0.53% | 2.90% | -4.81% | |
66 Neutral | $217.39B | 32.62 | 13.04% | 0.30% | 3.91% | 7.09% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
On January 16, 2026, Mettler-Toledo’s board appointed Michael J. Tokich as an independent director, effective February 5, 2026, expanding the board from nine to ten members with compensation aligned to the company’s other independent directors and no related-party arrangements disclosed. Announced publicly on January 20, 2026, the appointment brings to Mettler-Toledo nearly two decades of U.S. public company CFO experience from Tokich’s long tenure at healthcare and life sciences firm STERIS, bolstering the company’s financial, operational and IT expertise at board level and potentially strengthening its governance and strategic oversight for stakeholders.